Brought to you by 
ViroLogic provides HIV testing tools to Pfizer; concludes
19 May 2009
Executive Summary
ViroLogic (develops products to improve treatment of viral diseases) nonexclusively licensed certain patent rights and HIV assay technology to Pfizer for use in its HIV drug discovery and development program. It will also offer drug evaluation and/or clinical services.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Concluded
Deal Type
-
Alliance
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com